APNO is a recommended therapy by various breastfeeding organizations for breastfeeding moms to apply to the nipples after feedings. The ingredients are miconazole, betamethasone, and mupirocin.

I was unable to find safety data for possible exposure of the neonate/infant. My biggest concern is for oral absorption of topical betamethasone by the baby.

Our hospital has been compounding this for use in our patients, but I have some concerns given there isn't any true evidence of efficacy or safety.

I would appreciate any help or insight on this. Thank you.

Dear colleagues,
I would like to know the process for adding a new medication on the formulary. Especially when a decision is required to select 01 brand among multiple brands available for a generic. whats the criteria for selection? who is the decision maker; the pharmacy or a Purchase dept.?

If you could share your formulary addition policy that would be of great help.

thanks,
Saharish

Can you describe your dispensing practices for intralipids when the total Bag volume far exceeds the daily volume prescribed? Do you transfer to patient specific syringes? If so what is the allowed hang time? If you dispense bags what safety mechanisms do you have in place to prevent overdoses?

Which software or application your site use for reporting and analyzing ADRs and ADEs? Our system currently use the one from Datix but it is controlled by Risk and was not designed with specific ADR reporting and analzying capabilities (e.g. no probability scale). We are considering either EPIC or REDCap. Any input or insight is greatly appreciated!

Good afternoon, I'm wondering if anyone is willing to share how you organize your Med Safety Committee agenda? How do you determine what topics make it to the agenda? And if you work for a system, do all the facilities use the same agenda?

There's been lots posted about metrics, but I'm more interested in an agenda template.

For instance, here's a few things on ours: old business/follow-up, dashboard, preventable ADR reports, update from the system committee.

Thanks,
Joanie

I am looking for help on recommendations or guidelines regarding the utilization of "visual cues" to distinguish medications. I am working with a procedural area that is utilizing a specific type of syringe to differentiate a medication from other medications. The area is using a "control" syringe which is an IV syringe with plastic loops on it for a users fingers but it is being used to distinguish it from other IVs rather than for the need for the plastic loops.

Hello,

We are looking into RX crusher using the pill pouch with ENFit syringes. Does anyone have an experience with this product? If so, did you have any issues or challenges implementing it?

Thank you!

Good Morning All,
With the new changes in manufacturers' labeling of vitamin D products, we are trying to find a best solution with naming conventions in CPOE and on the final product label, marrying old way of thinking and ordering (in International Units) and new one (in microGRAMs).
How did your institution handle the transition?
Thanks.

Hello,

I am curious if anyone has had any experience in using the FDB Infusion Knowledge during the building or maintenance of drug libraries. I believe it's integrated with some Baxter pumps and also B Braun.

If so would love to hear the pros and cons that you or your facility may have encountered.

Thank you!

Ivy

A colleague told me that all hospital pharmacy cleanrooms are 503A compounding facilities, by default. It is my understanding that we are NOT considered a 503A compounding facility if we are only making products for patients that are admitted to our facility. If we were to sell our products to another facility in town (pursuant to a prescriber’s prescription), then we would be considered a 503A. How do others interpret this?